← Eichor
Condition: Oral Mucositis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Oral Mucositis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT05335434Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · 153 location(s) · NRG Oncology · NCT06532279Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy
NA · 20 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05892354Effects of Photobiomodulation (PBM) on Pain After Presentation of Aphthous Ulcers in Pediatric Dental Patients
Phase 4 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06819033Rice Bran Supplementation for Radiation-Induced Oral Mucositis in Head and Neck Cancer
NA · 1 location(s) · Christina Milad Lobos · NCT07242859Salivary E-cadherin, Calprotectin, and Matrix Metalloproteinase-9 Levels in Recurrent Aphthous Stomatitis
Phase N/A · 1 location(s) · Selin Yeşiltepe · NCT07141758Immediate Versus Delayed Loading of Single Posterior Zirconia Implants
Phase 4 · 1 location(s) · University of Milan · NCT05838365Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
Phase 2 · 1 location(s) · Brown University · NCT06974604The Preventive and Therapeutic Effects of Spirulina Preparations on Ulcers of Oral Mucosa
NA · 1 location(s) · The Fourth Affiliated Hospital of Zhejiang University School · NCT07723612Distance Between Dental Implants as a Risk Indicator for Peri-implant Disease.
Phase N/A · 1 location(s) · Universitat Internacional de Catalunya · NCT06364982A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in
Phase 1 · 2 location(s) · Mayo Clinic · NCT03017820Observational Study of OROSEDAL in Sore Throat and Minor Oral Lesions
Phase N/A · 1 location(s) · Laboratoires Elerte · NCT07620353Prevention of Oral Mucositis in Head and Neck Cancer.
NA · 1 location(s) · Catholic University of the Sacred Heart · NCT05853692Breathomics in the Diagnosis and Prediction of Radiotherapy-Induced Oropharyngeal Mucositis in Head and Neck Tumors
Phase N/A · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06767488Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic E
EARLY_Phase 1 · 1 location(s) · Peng Zhang · NCT06119490Occurrence of Peri-Implant Complications: A Multifactorial Cross-Sectional Study
Phase N/A · 1 location(s) · Center of Implantology, Oral and Maxillofacial Surgery, Bada · NCT07638969Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients
Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07400328A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cance
Phase 3 · 11 location(s) · OncoZenge AB · NCT07672236Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT01420562An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Pat
Phase 4 · 39 location(s) · AstraZeneca · NCT07357597LYell SYndrome MEsenchymal Stromal Cells Treatment
Phase 1/Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04711200Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT
Phase 3 · 2 location(s) · Instituto Nacional de Cancer, Brazil · NCT06071637Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms
Phase 3 · 21 location(s) · University Hospital, Rouen · NCT04227314Effect of Sodium Bicarbonate, Saline and Black Mulberry Syrup on Degree of Oral Mucositis in Children Receiving Chemothe
NA · 1 location(s) · Burdur Mehmet Akif Ersoy University · NCT06525402F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors)
NA · 1 location(s) · Georgetown University · NCT06315855Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis
NA · 1 location(s) · University of Pavia · NCT07491536The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness
NA · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT07053969Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology Patients
NA · 1 location(s) · The General Hospital of Western Theater Command · NCT06599346Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy
NA · 1 location(s) · Federal University of Minas Gerais · NCT06576986Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Peri-imp
NA · 1 location(s) · University of Catania · NCT05906810
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.